Dr. Pamela Hull is an Associate Professor in the Behavioral Science Department. She is a medical sociologist and community-engaged researcher with interests in the development, dissemination, and implementation of behavioral and health service interventions to promote cancer prevention behaviors and reduce cancer disparities. Her current research focuses on the implementation of evidence-based practices for cancer prevention and control, including HPV vaccination and obesity prevention, using implementation science and technology-based applications. She leads an R01 implementation science study aiming to increase HPV vaccination among adolescents in community-based pediatric primary care practices. She also leads the USDA-funded Children Eating Well (CHEW) grant (R01 equivalent), which focuses on a mobile phone application designed for early childhood obesity prevention among low-income families with preschool-aged children. She was recently funded as MPI (Merck Foundation) to evaluate delivery of psychosocial distress assessment and patient navigation for cancer patients through an interactive mobile application, which supports standards for quality cancer care. She collaborates as co-investigator on two external R01s and an industry-funded clinical trial. Dr. Hull serves as the Associate Director of Population Science and Community Impact in the UK Markey Cancer Center. As Associate Director, she leads the Community Impact Office to oversee the cancer center’s community outreach and engagement functions, and she oversees the cancer center’s population science research agenda and infrastructure. In this role, she serves as PI on a CDC grant on behalf of the state, in which her team manages Kentucky’s statewide cancer coalition (Kentucky Cancer Consortium) and the state’s Cancer Action Plan. She serves on multiple committees in the UK Markey Cancer Center, including the DEI Committee, Protocol Review and Monitoring Committee, Membership Committee, and Director’s Council. She currently mentors three early-career faculty at UK and a K01-funded URM early-career faculty at Meharry Medical College, as a postdoctoral fellow, a PhD student, a medical student, and an undergraduate student.
PhD, Sociology, Vanderbilt University MA, Sociology, Vanderbilt University BA, Sociology, Duke University
Dr. Hull is a medical sociologist with expertise in the development, dissemination and implementation of behavioral and health service interventions to promote cancer prevention behaviors in youth. Her research focuses on HPV vaccination, healthy eating, and physical activity, using implementation science and new technology applications. She has over 15 years of experience as an investigator conducting community-engaged research, and much of her work addresses health disparities among African American, Hispanic, and low-income populations, in collaboration with community partners.
Dr. Hull serves as Associate Director of Population Science and Community Impact in the UK Markey Cancer Center. In this role, she leads the Community Impact Office to oversee the cancer center’s community outreach and engagement functions, and she oversees MCC’s population science research agenda and infrastructure.
Ortiz AP, Soto-Salgado M, Calo WA, Hull PC, Fernandez ME, Colon-López V, Tortolero-Luna G. Elimination of cervical cancer in U.S. Hispanic populations: Puerto Rico as a case study. Prev Med. 2020. In press.
Shing JZ, Griffin MR, Nguyen LD, Slaughter JC, Mitchel EF, Pemmaraju M, Rentuza AB, Hull PC. Improving cervical precancer surveillance: Validity of claims-based prediction models in ICD-9 and ICD-10 eras. JNCI Cancer Spectr. 2020. In Press.
Cunningham-Erves J, Barajas C, Mayo-Gamble TL, McAfee C, Hull PC, Sanderson M, Canedo J, Beard K, Wilkins, CH. Formative research to design a culturally-appropriate cancer clinical trial education program to increase participation of African American and Latino communities. BMC Public Health. 2020. 20(1):840.
Cunningham-Erves J, Koyama T, Huang Y, Jones J, Wilkins CH, Harnack L, McAfee C, Hull PC. Providers’ perceptions of parental HPV vaccine hesitancy: A cross-sectional study. JMIR Cancer. 2019. 5(2):e13832.
Shing JZ, Hull PC, Zhu Y, Gargano JW, Markowitz LE, Cleveland AA, Pemmaraju M, Park IU, Whitney E, Mitchel EF, Griffin MR. Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006-2014: The impact of human papillomavirus vaccination. Papillomavirus Res. 2019; 7:141-149.
Weber SJ, Dawson D, Greene H, Hull PC. A review of smartphone applications for low-income participants in a public health program for women infants and children (WIC). JMIR mHealth uHealth. 2018; 6(11):e12261.
Hull PC, Buchowski M, Canedo JR, Beech BM, Du L, Koyama T, Zoorob R. Childhood obesity prevention trial for Hispanic families: Outcomes of the Healthy Families Study. Ped Obes. 2018; 13(11):686-696.
Odoh C, Sanderson M, Williams EA, Hull PC. Operationalizing outcome measures of HPV vaccination among adolescents. Public Health. 2018, 159:129-132
Hull PC, Emerson JS, Quirk ME, Canedo JR, Jones JL, Vylegzhanina V, Schmidt DC, Mulvaney SA, Beech BM, Briley C, Harris C, Husaini BA. A Smartphone app for families with preschool-aged children in a public nutrition program: Prototype development and beta-testing. JMIR mHealth uHealth. 2017; 5(8):e102.
Sanderson M, Canedo JR, Khabele D, Fadden MK, Harris C, Beard K, Burress M, Pinkerton H, Jackson C, Mayo-Gamble T, Hargreaves M, Hull PC. Pragmatic trial of an intervention to increase human papillomavirus vaccination in safety-net clinics. BMC Public Health. 2017; 17(1)158.
Selove R, Foster M, Mack R, Sanderson M, Hull PC. Using an implementation research framework to identify potential facilitators and barriers of an intervention to increase HPV vaccine uptake. Journal of Public Health Management & Practice. 2017; 23(3):e1-e9. PMID: 27902559; PMCID: PMC5373968.